Protein level may predict immunotherapy success in four cancers
Knowledge-focused
Recruiting now
This study is observing 300 adults with kidney, bladder, lung, or liver cancer who are starting immunotherapy (PD-1/PDL-1 inhibitors). Researchers will measure a protein called Galectin-3 in the blood before each treatment to see if its level is linked to how well the therapy wor…
Sponsor: Daniel Keizman • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC